US FDA approves Regeneron’s ultra-rare blood disease drug
By Pratik Jain (Reuters) -Regeneron Pharmaceuticals said on Friday the U.S. health regulator approved its...
By Pratik Jain (Reuters) -Regeneron Pharmaceuticals said on Friday the U.S. health regulator approved its...
By Zeba Siddiqui SAN FRANCISCO (Reuters) -Google-owned U.S. cybersecurity firm Mandiant said on Thursday it...
By Bhanvi Satija and Pratik Jain (Reuters) -The U.S. Food and Drug Administration on Monday...
A massive financial move on Adobe (NASDAQ:ADBE) has caught our eye. Is this a...
The U.S. administration has tightened its belt on tech investments in China, hinting...
Airbnb (NASDAQ:ABNB) is turning Wall Street heads, soaring over 60% this year, proving...
The Big Picture: A strategic alliance between J.P. Morgan and TIFIN, two major...
🔎 Flashback: The U.S. Justice Department and Google are tangled in a legal...
By Jack Kim SEOUL (Reuters) – North Korean leader Kim Jong Un has instructed factories...
Situation Overview China has taken an alarming step, publicly showcasing its military preparedness...